Will 18F flurpiridaz replace 82rubidium as the most commonly used perfusion tracer for PET myocardial perfusion imaging?
- PMID: 30488324
- DOI: 10.1007/s12350-017-1153-z
Will 18F flurpiridaz replace 82rubidium as the most commonly used perfusion tracer for PET myocardial perfusion imaging?
Comment on
-
Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging.J Nucl Cardiol. 2019 Dec;26(6):2018-2030. doi: 10.1007/s12350-018-01484-z. Epub 2018 Nov 28. J Nucl Cardiol. 2019. PMID: 30488323
References
-
- Cerqueiera MD, Allman KC, Ficaro EP, Hansen CL, Nichols KJ, Thompson RC, et al. Recommendations for reducing radiation exposure in myocardial perfusion imaging. J Nucl Cardiol. 2010;17:709–18. - DOI
-
- Dorbala S, Hachamovitch R, Curillova Z, Vangala D, Kwong RY, DiCarli MF. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging. 2009;2:846–54. - DOI
-
- McArdle BA, Dowsley TF, DekempRA Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? A systematic review and meta-analysis. J Am Coll Cardiol. 2012;60:1828–37. - DOI
-
- Lortie M, Beanlands RS, Yoshinaga K, Klein R, Dasilva JN, Dekemp RA. Quantification of myocardial blood flow with 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging. 2007;34:1765–74. - DOI
-
- Garcia EV, Galt JR, Faber TL, et al. Principles of nuclear cardiology imaging. In: Dilsizian V, Narula J, editors. Atlas of Nuclear Cardiology. 4th ed. New York: Springer; 2013. p. 1–53.